Changing patterns of opioid initiation for pain management in Ontario, Canada: A population-based cross-sectional study

Author:

Gomes TaraORCID,Men Siyu,Campbell Tonya J.ORCID,Tadrous MinaORCID,Mamdani Muhammad M.,Paterson J. MichaelORCID,Juurlink David N.

Abstract

Introduction The recent publication of a national guideline and quality standards in Canada have provided clinicians with new, evidence-based recommendations on safe, appropriate opioid use. We sought to characterize how well opioid initiation practices aligned with these recommendations before and following their release. Methods We conducted a population-based study among people initiating opioids prior to the release of national guidelines (April 2015—March 2016; fiscal year [FY] 2015) and in the most recent year available (January—December 2019) in Ontario, Canada. We used linked administrative claims data to ascertain the apparent indication for opioid therapy, and characterized the initial daily dose (milligrams morphine or equivalent; MME) and prescription duration for each indication. Results In FY2015, 653,885 individuals commenced opioids, compared to 571,652 in 2019. Over time, there were small overall reductions in the prevalence of initial daily doses exceeding 50MME (23.9% vs. 20.1%) and durations exceeding 7 days (17.4% vs. 14.8%); but the magnitude of the reductions varied widely by indication. The prevalence of high dose (>50MME) initial prescriptions reduced significantly across all indications, with the exception of dentist-prescribed opioids (13.6% vs. 12.1% above 50MME). In contrast, there was little change in initial durations exceeding 7 days across most indications, with the exception of some surgical indications (e.g. common excision; 9.3% vs. 6.2%) and among those in palliative care (35.2% vs. 29.2%). Conclusion Despite some modest reductions in initiation of high dose and long duration prescription opioids between 2015 and 2019, clinical practice is highly variable, with opioid prescribing practices influenced by clinical indication. These findings may help identify medical specialties well-suited to targeted interventions to promote safer opioid prescribing.

Funder

Canadian Institutes of Health Research

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference29 articles.

1. Government of Canada. Opioid and Stimulant-Related Harm in Canada 2020 https://health-infobase.canada.ca/substance-related-harms/opioids-stimulants/graphs?index=791.

2. U.S. Centers for Disease Control and Prevention. Opioid Data Analysis and Resources 2021 https://www.cdc.gov/drugoverdose/data/analysis.html.

3. Public Health Ontario. Interactive Opioid Tool: Opioid-related morbidity and mortality in Ontario: Public Health Ontario; 2019 https://www.publichealthontario.ca/Data%20and%20Analysis/Substance%20Use/Interactive%20Opioid%20Tool.

4. Understanding the Implications of a Shifting Opioid Landscape in Ontario;T Gomes;Healthc Q,2019

5. U.S. Centers for Disease Control and Prevention. Understanding the Epidemic 2020 https://www.cdc.gov/drugoverdose/epidemic/index.html.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3